These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20159648)

  • 21. Cellular and molecular imaging with targeted contrast ultrasound.
    Behm CZ; Lindner JR
    Ultrasound Q; 2006 Mar; 22(1):67-72. PubMed ID: 16641795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications.
    Klibanov AL
    Invest Radiol; 2006 Mar; 41(3):354-62. PubMed ID: 16481920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular imaging of cardiovascular disease using ultrasound.
    Villanueva FS
    J Nucl Cardiol; 2008; 15(4):576-86. PubMed ID: 18674725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Science to practice: will magnetic guidance of microbubbles play a role in clinical molecular imaging?
    Nahrendorf M; Sosnovik DE
    Radiology; 2011 Aug; 260(2):309-10. PubMed ID: 21778448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relevance of contrast ultrasound with microbubbles in vascular medecine].
    Erdmann A; Ney B; Alatri A; Calanca L; Mazzolai L
    Rev Med Suisse; 2016 Dec; 12(542):2131-2134. PubMed ID: 28700167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo demonstration of cancer molecular imaging with ultrasound radiation force and buried-ligand microbubbles.
    Borden MA; Streeter JE; Sirsi SR; Dayton PA
    Mol Imaging; 2013 Sep; 12(6):357-63. PubMed ID: 23981781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies.
    Streeter JE; Gessner R; Miles I; Dayton PA
    Mol Imaging; 2010 Apr; 9(2):87-95. PubMed ID: 20236606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound contrast agents for ultrasound molecular imaging.
    Tranquart F; Arditi M; Bettinger T; Frinking P; Hyvelin JM; Nunn A; Pochon S; Tardy I
    Z Gastroenterol; 2014 Nov; 52(11):1268-76. PubMed ID: 25390214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals.
    Schutt EG; Klein DH; Mattrey RM; Riess JG
    Angew Chem Int Ed Engl; 2003 Jul; 42(28):3218-35. PubMed ID: 12876730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of ultrasound contrast agent microbubbles in preclinical research: recommendations for small animal imaging.
    Hyvelin JM; Tardy I; Arbogast C; Costa M; Emmel P; Helbert A; Theraulaz M; Nunn AD; Tranquart F
    Invest Radiol; 2013 Aug; 48(8):570-83. PubMed ID: 23511194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound contrast agents: an overview.
    Cosgrove D
    Eur J Radiol; 2006 Dec; 60(3):324-30. PubMed ID: 16938418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular imaging in oncology using targeted ultrasound contrast agents].
    Palmowski M; Palmowski M; Hauff P; Kiessling F
    Praxis (Bern 1994); 2009 May; 98(11):597-602. PubMed ID: 19472145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications in progressive diabetic nephropathy.
    Leong-Poi H
    Semin Nephrol; 2012 Sep; 32(5):494-504. PubMed ID: 23062991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular sonography with targeted microbubbles: current investigations and potential applications.
    Hwang M; Lyshchik A; Fleischer AC
    Ultrasound Q; 2010 Jun; 26(2):75-82. PubMed ID: 20498563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging.
    Pysz MA; Willmann JK
    Gastroenterology; 2011 Mar; 140(3):785-90. PubMed ID: 21255573
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular ultrasound imaging: current status and future directions.
    Deshpande N; Needles A; Willmann JK
    Clin Radiol; 2010 Jul; 65(7):567-81. PubMed ID: 20541656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries.
    Kornmann LM; Reesink KD; Reneman RS; Hoeks AP
    Ultrasound Med Biol; 2010 Feb; 36(2):181-91. PubMed ID: 20018434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted ultrasound imaging using microbubbles.
    Villanueva FS; Wagner WR; Vannan MA; Narula J
    Cardiol Clin; 2004 May; 22(2):283-98, vii. PubMed ID: 15158940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of bound microbubbles in ultrasound molecular imaging.
    Daeichin V; Akkus Z; Skachkov I; Kooiman K; Needles A; Sluimer J; Janssen B; Daemen MJ; van der Steen AF; de Jong N; Bosch JG
    IEEE Trans Ultrason Ferroelectr Freq Control; 2015 Jun; 62(6):1190-200. PubMed ID: 26067053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.